William Blair Has Optimistic Outlook of SLP Q1 Earnings

Simulations Plus, Inc. (NASDAQ:SLP) – Equities researchers at William Blair raised their Q1 2025 EPS estimates for Simulations Plus in a research note issued to investors on Tuesday, November 5th. William Blair analyst M. Smock now expects that the technology company will earn $0.16 per share for the quarter, up from their previous estimate of $0.08. William Blair has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.11 per share. William Blair also issued estimates for Simulations Plus’ Q2 2025 earnings at $0.27 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.37 EPS, FY2025 earnings at $1.12 EPS, Q2 2026 earnings at $0.35 EPS, Q3 2026 earnings at $0.40 EPS, Q4 2026 earnings at $0.45 EPS and FY2026 earnings at $1.39 EPS.

A number of other equities research analysts also recently commented on the company. KeyCorp started coverage on Simulations Plus in a research report on Monday, July 29th. They issued an “overweight” rating and a $47.00 target price on the stock. BTIG Research lowered their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, October 24th. JMP Securities began coverage on Simulations Plus in a research report on Tuesday, July 16th. They set a “market perform” rating on the stock. Finally, StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $54.50.

Simulations Plus Trading Down 0.4 %

SLP opened at $30.70 on Friday. Simulations Plus has a twelve month low of $27.22 and a twelve month high of $51.22. The firm has a market capitalization of $616.15 million, a PE ratio of 62.65 and a beta of 0.71. The firm’s 50-day moving average price is $31.71 and its 200 day moving average price is $39.54.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.04 by $0.02. The company had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The firm’s revenue was up 19.9% on a year-over-year basis. During the same quarter last year, the business earned $0.18 earnings per share.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total transaction of $625,200.00. Following the transaction, the director now owns 3,481,592 shares of the company’s stock, valued at approximately $108,834,565.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Over the last ninety days, insiders sold 60,750 shares of company stock worth $1,905,655. Corporate insiders own 20.90% of the company’s stock.

Institutional Investors Weigh In On Simulations Plus

Several large investors have recently made changes to their positions in the company. Public Employees Retirement System of Ohio bought a new stake in Simulations Plus during the 1st quarter worth about $1,082,000. Silvercrest Asset Management Group LLC acquired a new stake in shares of Simulations Plus during the first quarter worth $4,717,000. Deerfield Management Company L.P. Series C bought a new stake in Simulations Plus in the second quarter valued at about $811,000. Allspring Global Investments Holdings LLC acquired a new position in Simulations Plus in the first quarter valued at about $70,000. Finally, Tributary Capital Management LLC boosted its holdings in Simulations Plus by 54.7% during the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after buying an additional 115,122 shares during the last quarter. Institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.